Activating Kras mutations could not be detected in over one quarter of the approximate 50 tumors tested, and in the tumors which showed a positive PCR signal, whether the point mutation occurred in any appreciable fractions of the tumor cell population could not be determined (18). Here, KRAS is linked to neoplasm.